Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

Author： Lenz O.   Schmid B.   Kilter H.   La Rosee K.   Flesch M.   Kuhn-Regnier F.   Sudkamp M.   Bohm M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.294, Iss.1, 1995-01, pp. : 17-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I.   Gonzalez W.   Doucet J.   Fournie-Zaluski M.-C.   Roques B.P.   Michel J.-B.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite

Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro

By Persson K.   Whiss P.A.   Nyhlen K.   Jacobsson-Strier M.   Glindell M.   Andersson R.G.G.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 15-23

Elsevier

Access to resources Recommend Favorite

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 723-735

Bentham Science Publishers

Access to resources Recommend Favorite